Canada Goose Under Investigation, Stock Price Drops
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2d ago
0mins
Should l Buy GOOS?
Source: Globenewswire
- Investigation Launched: Holzer & Holzer, LLC is investigating whether Canada Goose Holdings Inc. complied with federal securities laws, indicating potential legal risks that could undermine investor confidence.
- Earnings Report Released: The Q3 fiscal 2026 report revealed that Canada Goose stated, “Margins this quarter reflected deliberate choices we made to expand product relevance,” yet failed to boost stock prices, leading to a decline instead.
- Stock Price Reaction: Following the earnings release, Canada Goose's stock price dropped, reflecting market concerns over its financial performance and future outlook, which could impact the company's financing capabilities and competitive position.
- Legal Consultation Offered: Holzer & Holzer encourages affected investors to reach out to discuss their legal rights, demonstrating the firm's proactive stance in protecting shareholder interests, which may prompt increased investor engagement and actions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GOOS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GOOS
Wall Street analysts forecast GOOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GOOS is 13.09 USD with a low forecast of 8.65 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
2 Buy
3 Hold
1 Sell
Hold
Current: 10.650
Low
8.65
Averages
13.09
High
16.00
Current: 10.650
Low
8.65
Averages
13.09
High
16.00
About GOOS
Canada Goose Holdings Inc. is a Canada-based company that operates a performance luxury outerwear, apparel, footwear and accessories brand. The Company designs, manufactures, and sells performance luxury apparel for men, women, youth, children, and babies. The Company’s product offerings include various styles of down-filled outerwear, rain and everyday jackets, fleece, vests, apparel, footwear, and accessories for the fall, winter, and spring seasons. The products it manufactures and sells are marketed under the Company’s brands: Canada Goose, Snow Goose and Baffin. Its apparel products include men’s and women’s leisure wear, including knitwear, sweats, and t-shirts. Its other outerwear products include rain and everyday collections, jackets for everyday occasions, fleece, and vests. The Company’s footwear and accessories products encompass men’s, women’s, and children’s products, including sneakers, boots, hats, scarves, gloves, hood trims, socks, bags and eyewear.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Kessler Investment Group Increases GOOS Holdings
- Share Acquisition Details: Kessler Investment Group disclosed on February 3, 2026, via an SEC filing, the acquisition of 379,516 shares of Canada Goose (GOOS) with an estimated transaction value of $5.05 million, reflecting confidence in the luxury market.
- Asset Management Proportion: This transaction brings Kessler's total GOOS holdings to 678,892 shares valued at $8.79 million, representing 3.7% of its 13F reportable assets, making it the fund's 10th-largest holding and indicating a strategic focus on luxury goods.
- Market Performance Analysis: As of February 6, 2026, GOOS shares were priced at $11.24, up 14.7% over the past year, outperforming the S&P 500 by one percentage point, demonstrating its competitive position in the luxury market.
- Financial Health Status: Despite Canada Goose reporting a 14% increase in total sales and a 20% rise in North American revenue in its recent Q3 earnings, its margins and earnings fell short of expectations, prompting investors to monitor its future financial performance and market reactions.
See More
Kessler Investment Group Increases Canada Goose Holdings to 3.7% of AUM
- Share Acquisition: On February 3, 2026, Kessler Investment Group purchased an additional 379,516 shares of Canada Goose (GOOS) for approximately $5.05 million, reflecting confidence in the luxury market.
- Asset Allocation Shift: This acquisition brings GOOS to 3.7% of Kessler's reportable assets under management, indicating its increasing significance within the investment portfolio.
- Performance Overview: Despite GOOS shares priced at $11.24 on February 6, 2026, reflecting a 14.7% increase over the past year, the stock fell over 10% following disappointing earnings, prompting caution among investors.
- Market Outlook: Kessler's increased stake suggests optimism about GOOS's long-term potential, particularly as sales in new product categories have doubled year-over-year, indicating that if the company can manage costs and maintain brand premium, substantial returns may be on the horizon.
See More
Wall Street's Latest Rating Changes Overview
- Amazon Downgrade: DA Davidson downgraded Amazon from Buy to Neutral, citing concerns that Amazon Web Services (AWS) is losing market share amid competition from Microsoft and Google, indicating a potential need for increased investment to regain its leading position in the cloud computing sector.
- Merit Medical Initiation: BTIG initiated coverage on Merit Medical with a Buy rating, highlighting its comprehensive product portfolio used across various interventional procedures, which underscores the company's high-quality positioning and growth potential in the medical device market.
- JBS Buy Rating: UBS initiated coverage on Brazilian meat company JBS with a Buy rating and a price target of $19.5 per share, implying a 23% upside, reflecting market confidence in its re-rating and potential stock price appreciation.
- Vistra Upgrade: Goldman Sachs upgraded Vistra from Neutral to Buy, projecting a potential EBITDA increase of 3-9% by 2028, indicating investor optimism regarding its future profitability and growth prospects in the nuclear energy sector.
See More
Barclays Downgrades Canada Goose to Underweight and Lowers Target Price to $10 from $12
- Stock Price Adjustment: Barclays has reduced its target price for Canadian Goose shares from $12 to $10.
- Weight Class Change: The company has also adjusted its weight rating from equal weight to underweight.
See More
Significant Stock Movements in Midday Trading
- McKesson Earnings Beat: McKesson's fiscal third-quarter earnings per share exceeded Wall Street's highest estimates, and the adjusted full-year EPS guidance was raised above analyst consensus, leading to a 16% stock price increase, indicating strong performance in the medical supply sector.
- Bob's Discount Furniture IPO: Bob's Discount Furniture debuted on the New York Stock Exchange with shares priced at $17, recently rising 10%, marking a successful entry into the public market and laying the groundwork for future growth.
- Fluence Energy Earnings Miss: Fluence Energy reported first-quarter revenue of $475.2 million, falling short of the $481.2 million consensus, with a per-share loss of 34 cents missing the 21-cent loss estimate, resulting in a 31% stock price drop, reflecting market concerns over its profitability.
- Cardinal Health Guidance Raised: Cardinal Health reported quarterly adjusted earnings of $2.63 per share, exceeding the $2.36 consensus, with revenue of $65.63 billion surpassing the $64.14 billion estimate, leading to an 8% stock price increase, showcasing strong growth potential in the healthcare services sector.
See More
Canada Goose Under Investigation, Stock Price Drops
- Investigation Launched: Holzer & Holzer, LLC is investigating whether Canada Goose Holdings Inc. complied with federal securities laws, indicating potential legal risks that could undermine investor confidence.
- Earnings Report Released: The Q3 fiscal 2026 report revealed that Canada Goose stated, “Margins this quarter reflected deliberate choices we made to expand product relevance,” yet failed to boost stock prices, leading to a decline instead.
- Stock Price Reaction: Following the earnings release, Canada Goose's stock price dropped, reflecting market concerns over its financial performance and future outlook, which could impact the company's financing capabilities and competitive position.
- Legal Consultation Offered: Holzer & Holzer encourages affected investors to reach out to discuss their legal rights, demonstrating the firm's proactive stance in protecting shareholder interests, which may prompt increased investor engagement and actions.
See More
Kessler Investment Group Increases GOOS Holdings
- Share Acquisition Details: Kessler Investment Group disclosed on February 3, 2026, via an SEC filing, the acquisition of 379,516 shares of Canada Goose (GOOS) with an estimated transaction value of $5.05 million, reflecting confidence in the luxury market.
- Asset Management Proportion: This transaction brings Kessler's total GOOS holdings to 678,892 shares valued at $8.79 million, representing 3.7% of its 13F reportable assets, making it the fund's 10th-largest holding and indicating a strategic focus on luxury goods.
- Market Performance Analysis: As of February 6, 2026, GOOS shares were priced at $11.24, up 14.7% over the past year, outperforming the S&P 500 by one percentage point, demonstrating its competitive position in the luxury market.
- Financial Health Status: Despite Canada Goose reporting a 14% increase in total sales and a 20% rise in North American revenue in its recent Q3 earnings, its margins and earnings fell short of expectations, prompting investors to monitor its future financial performance and market reactions.
See More
Kessler Investment Group Increases Canada Goose Holdings to 3.7% of AUM
- Share Acquisition: On February 3, 2026, Kessler Investment Group purchased an additional 379,516 shares of Canada Goose (GOOS) for approximately $5.05 million, reflecting confidence in the luxury market.
- Asset Allocation Shift: This acquisition brings GOOS to 3.7% of Kessler's reportable assets under management, indicating its increasing significance within the investment portfolio.
- Performance Overview: Despite GOOS shares priced at $11.24 on February 6, 2026, reflecting a 14.7% increase over the past year, the stock fell over 10% following disappointing earnings, prompting caution among investors.
- Market Outlook: Kessler's increased stake suggests optimism about GOOS's long-term potential, particularly as sales in new product categories have doubled year-over-year, indicating that if the company can manage costs and maintain brand premium, substantial returns may be on the horizon.
See More
Wall Street's Latest Rating Changes Overview
- Amazon Downgrade: DA Davidson downgraded Amazon from Buy to Neutral, citing concerns that Amazon Web Services (AWS) is losing market share amid competition from Microsoft and Google, indicating a potential need for increased investment to regain its leading position in the cloud computing sector.
- Merit Medical Initiation: BTIG initiated coverage on Merit Medical with a Buy rating, highlighting its comprehensive product portfolio used across various interventional procedures, which underscores the company's high-quality positioning and growth potential in the medical device market.
- JBS Buy Rating: UBS initiated coverage on Brazilian meat company JBS with a Buy rating and a price target of $19.5 per share, implying a 23% upside, reflecting market confidence in its re-rating and potential stock price appreciation.
- Vistra Upgrade: Goldman Sachs upgraded Vistra from Neutral to Buy, projecting a potential EBITDA increase of 3-9% by 2028, indicating investor optimism regarding its future profitability and growth prospects in the nuclear energy sector.
See More
Barclays Downgrades Canada Goose to Underweight and Lowers Target Price to $10 from $12
- Stock Price Adjustment: Barclays has reduced its target price for Canadian Goose shares from $12 to $10.
- Weight Class Change: The company has also adjusted its weight rating from equal weight to underweight.
See More
Significant Stock Movements in Midday Trading
- McKesson Earnings Beat: McKesson's fiscal third-quarter earnings per share exceeded Wall Street's highest estimates, and the adjusted full-year EPS guidance was raised above analyst consensus, leading to a 16% stock price increase, indicating strong performance in the medical supply sector.
- Bob's Discount Furniture IPO: Bob's Discount Furniture debuted on the New York Stock Exchange with shares priced at $17, recently rising 10%, marking a successful entry into the public market and laying the groundwork for future growth.
- Fluence Energy Earnings Miss: Fluence Energy reported first-quarter revenue of $475.2 million, falling short of the $481.2 million consensus, with a per-share loss of 34 cents missing the 21-cent loss estimate, resulting in a 31% stock price drop, reflecting market concerns over its profitability.
- Cardinal Health Guidance Raised: Cardinal Health reported quarterly adjusted earnings of $2.63 per share, exceeding the $2.36 consensus, with revenue of $65.63 billion surpassing the $64.14 billion estimate, leading to an 8% stock price increase, showcasing strong growth potential in the healthcare services sector.
See More
Canada Goose Under Investigation, Stock Price Drops
- Investigation Launched: Holzer & Holzer, LLC is investigating whether Canada Goose Holdings Inc. complied with federal securities laws, indicating potential legal risks that could undermine investor confidence.
- Earnings Report Released: The Q3 fiscal 2026 report revealed that Canada Goose stated, “Margins this quarter reflected deliberate choices we made to expand product relevance,” yet failed to boost stock prices, leading to a decline instead.
- Stock Price Reaction: Following the earnings release, Canada Goose's stock price dropped, reflecting market concerns over its financial performance and future outlook, which could impact the company's financing capabilities and competitive position.
- Legal Consultation Offered: Holzer & Holzer encourages affected investors to reach out to discuss their legal rights, demonstrating the firm's proactive stance in protecting shareholder interests, which may prompt increased investor engagement and actions.
See More
